Private company

BB Biotech

Logo: BB Biotech AG, Public domain, via Wikimedia Commons5

Swiss company based in Schaffhausen, founded in 19931

BB Biotech AG is a Swiss investment company in the field of biotechnology. The company invests mainly in the United States and Western Europe and is managed by Bellevue Asset Management, a division of Bellevue Group, which is listed on the Swiss Stock Exchange. It is one of the largest investment companies in the biotech sector.3 Wikipedia text CC BY-SA 4.0

Last updated Oct 20, 2026.

Overview

Nov 9, 1993Founded1
  • HeadquartersSchaffhausen1
  • Founded inSchaffhausen1
  • Websitewww.bbbiotech.ch
  • Legal formAktiengesellschaft1
  • LEI391200MBZQNPFHIVKO344
  • StatusActive4
  • LEI statusIssued and current4
  • Registered addressSchwertstrasse 6, 8200 Schaffhausen, Switzerland4
  • Registered withMinistry of Justice, CHE-102.169.6274

BB Biotech AG is a Swiss investment company in the field of biotechnology. The company invests mainly in the United States and Western Europe and is managed by Bellevue Asset Management, a division of Bellevue Group, which is listed on the Swiss Stock Exchange.3

Corporate structure

BB Biotech sits at the top of its group. 5 entities, 2 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

  • BB Biotech Schaffhausen, Switzerland
    • Biotech Focus N.V. Subsidiary · Willemstad, Curaçao
    • Biotech Growth N.V. Subsidiary · Willemstad, Curaçao
    • Biotech Invest N.V. Subsidiary · Willemstad, Curaçao
    • Biotech Target N.V. Subsidiary · Willemstad, Curaçao

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0). Each entity in the chart links to its source.

The story

BB Biotech was founded as an Aktiengesellschaft on November 9, 1993 in Schaffhausen, Switzerland. The company's shares have been traded on the SIX Swiss Exchange since December 27, 1993, and since December 10, 1997 on the German Deutsche Börse in Frankfurt. BB Biotech was listed on the TecDAX from 2003 to June 2012, and returned to it again between September 2012 and June 2015. The shares were listed on the Italian Nuovo Mercato from October 19, 2000 to September 4, 2023, since September 2005 in the Star segment (TechStar).

From Wikipedia’s article on BB Biotech, shared under CC BY-SA 4.0.6

Timeline

  1. Nov 9, 1993Founded Founded in Schaffhausen1

Filings

23 filings to the SEC since October 2021: 23 other. The latest 20:

  1. Aug 31, 2026N-PX EDGAR
  2. Aug 14, 202613F-NT EDGAR
  3. May 15, 202613F-NT EDGAR
  4. Feb 17, 202613F-NT EDGAR
  5. Nov 14, 202513F-NT EDGAR
  6. Aug 29, 2025N-PX EDGAR
  7. Aug 14, 202513F-NT EDGAR
  8. May 14, 202513F-NT EDGAR
  9. Apr 7, 2025N-PX EDGAR
  10. Feb 14, 202513F-NT EDGAR
  11. Nov 14, 202413F-NT EDGAR
  12. Aug 14, 202413F-NT EDGAR
  13. May 15, 202413F-NT EDGAR
  14. Feb 14, 202413F-NT EDGAR
  15. Nov 14, 202313F-NT EDGAR
  16. Aug 14, 202313F-NT EDGAR
  17. May 15, 202313F-NT EDGAR
  18. Feb 14, 202313F-NT EDGAR
  19. Nov 14, 202213F-NT EDGAR
  20. Aug 11, 202213F-NT EDGAR

The 23 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

SEC filer profile

How BB Biotech is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARBB BIOTECH AG2
  • CIK0000924223
  • Incorporated inSwitzerland2
  • Fiscal year endsDecember 312
  • Business addressSchwertstrasse 6, Schaffhausen, 8200, Switzerland2
  • Phone411724 59 592
  • On EDGAR sinceJun 2, 19942
  • Filings558 in all: SC 13G/A (184), 4 (141), 13F-HR (81), SC 13G (57), SC 13D/A (30), 13F-NT (29), SC 13D (10), 3 (9)2
    All 11 form types

    SCHEDULE 13G/A (9), 13F-HR/A (5), N-PX (3)

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6